Traitement des dystrophies rétiniennes affectant l’épithélium pigmentaire par ingénierie tissulaire fondée sur les cellules souches embryonnaires humaines

0 avis

Traitement des dystrophies rétiniennes affectant l’épithélium pigmentaire par ingénierie tissulaire fondée sur les cellules souches embryonnaires humaines

Archive ouverte

Ben M’barek, Karim | Habeler, Walter | Goureau, Olivier | Monville, Christelle

Edité par CCSD ; EDP Sciences -

International audience. No abstract available

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering

Archive ouverte | Ben M’barek, Karim | CCSD

International audience. Retinal degeneration is an irreversible phenomenon caused by various disease conditions including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). During the course of th...

Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine

Archive ouverte | Ben M’barek, Karim | CCSD

International audience. Recent clinical trials based on human pluripotent stem cell-derived retinal pigment epithelium cells (hPSC-RPE cells) were clearly a success regarding safety outcomes. However the delivery st...

Photoreceptor Cell Replacement Using Pluripotent Stem Cells: Current Knowledge and Remaining Questions

Archive ouverte | Monville, Christelle | CCSD

International audience. Retinal degeneration is an increasing global burden without cure for the majority of patients. Once retinal cells have degenerated, vision is permanently lost. Different strategies have been ...

Chargement des enrichissements...